GM-CSF affects hypothalamic neurotransmitter levels in mice: involvement of interleukin-1

Neuroreport. 1997 Nov 10;8(16):3587-90. doi: 10.1097/00001756-199711100-00033.

Abstract

We studied the effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on the brain levels of several neurotransmitters in mice. Administration of GM-CSF (5.0 and 10 microg, i.p.) significantly reduced the hypothalamic levels of glutamine, glutamic acid, GABA and aspartic acid. GM-CSF (5.0 microg, i.p.) also induced a significant reduction of norepinephrine and serotonin levels in the hypothalamus, without affecting dopamine levels. The hippocampal levels of neurotransmitters were not modified by GM-CSF administration. The peripheral administration of a specific interleukin-1 receptor antagonist (IL-1ra, 50 microg, i.p.) blocked the effects of GM-CSF. These results confirm our previous behavioural data suggesting that GM-CSF is able to exert neuromodulatory actions.

MeSH terms

  • Animals
  • Aspartic Acid / metabolism
  • Dopamine / metabolism
  • Glutamic Acid / metabolism
  • Glutamine / metabolism
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / physiology
  • Male
  • Mice
  • Neurotransmitter Agents / metabolism*
  • Norepinephrine / metabolism
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Recombinant Proteins / pharmacology
  • Serotonin / metabolism
  • Sialoglycoproteins / pharmacology*
  • gamma-Aminobutyric Acid / metabolism

Substances

  • IL1RN protein, human
  • Il1rn protein, mouse
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Neurotransmitter Agents
  • Receptors, Interleukin-1
  • Recombinant Proteins
  • Sialoglycoproteins
  • Glutamine
  • Aspartic Acid
  • Serotonin
  • Glutamic Acid
  • gamma-Aminobutyric Acid
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Dopamine
  • Norepinephrine